Pages that link to "Q39285249"

The following pages link to Polyvalent recombinant antigens: a new vaccine strategy (Q39285249):

Displaying 16 items.

• Universal influenza vaccines, a dream to be realized soon. (Q30361950) (← links)
• New technologies for making vaccines (Q33589117) (← links)
• Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery (Q33878517) (← links)
• The potential of plant viral vectors and transgenic plants for subunit vaccine production (Q34806017) (← links)
• Vaccine delivery using nanoparticles. (Q36712817) (← links)
• Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles (Q36796177) (← links)
• A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice (Q38885776) (← links)
• Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle (Q40061756) (← links)
• Expression vectors for the construction of hybrid Ty-VLPs (Q43738141) (← links)
• Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus (Q45744081) (← links)
• Rapid monitoring of virus-like particles using an optical biosensor: a feasibility study (Q45753456) (← links)
• Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles (Q45769758) (← links)
• Selective release of recombinant protein particles (VLPs) from yeast using a pure lytic glucanase enzyme. (Q52510364) (← links)
• Nanoparticle Vaccines Against Infectious Diseases (Q58583890) (← links)
• Production and purification of hybrid Ty-VLPs (Q72553177) (← links)
• Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials (Q90725000) (← links)